For the first time, the World Health Organization has issued guidelines on testing, treating and managing latent TB infection in individuals with high risk of developing disease.

The guidance lists five conditions that must be in place if delamanid is used to treat adults with MDR-TB.

WHO’s "Global Tuberculosis Report 2014" shows that 9 million people developed TB in 2013, and 1.5 million died, including 360 000 people who were HIV positive.

Report of a consensus meeting convened by the Global TB Programme of the World Health Organization.

The training focuses on building the capacity of health care workers at the primary and secondary level to address and manage TB in children.

The Handbook has been developed for the purpose of describing ways to implement established WHO policies relevant for the management of MDR-TB.

WHO HQ in collaboration with WHO AFRO is organising a training course for consultants in Programmatic Management of Drug-resistant TB (PMDT) in Durban, South Africa from 24 November to 2 December 2014 and is inviting expressions of interest from potential candidates to be considered for training.

Sunday 20 July 2014 | Promenade Room 3, Crowne Promenade, 8 Whiteman St, Melbourne, Victoria, Australia

The handbook shows how to use various data sources, presents existing tools to analyse the quality of data and describes methods to estimate the burden of TB and related trends.

Foreward